| Nov 12 |
MediWound to Report Third Quarter 2024 Financial Results
|
| Oct 27 |
MediWound's (NASDAQ:MDWD) investors will be pleased with their stellar 125% return over the last year
|
| Oct 23 |
Rosalind Advisors, Inc. Increases Stake in MediWound Ltd
|
| Oct 10 |
MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers
|
| Sep 3 |
MediWound to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 21 |
MediWound Ltd.'s (NASDAQ:MDWD) top owners are retail investors with 38% stake, while 28% is held by institutions
|
| Aug 14 |
MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript
|
| Aug 14 |
MediWound (MDWD) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 14 |
MediWound: Q2 Earnings Snapshot
|
| Aug 14 |
MediWound GAAP EPS of -$0.68 misses by $0.26, revenue of $5.06M in-line
|
